Citations

Clear

116 citation(s) found for "Davis, Mark".

Topically Applied Midodrine, 0.2%, an α1-Agonist, for the Treatment of Erythromelalgia
Davis, Mark D.P. , Morr, Claudia, Warndahl, Roger, Sandroni, Paola , Morr, Claudia S, Warndahl, Roger A

Mayo Clinic

JAMA Dermatology | May 6, 2015 | Volume: 151 | Issue: 9 | Pages: 1025

10.1001/jamadermatol.2015.0511 | PMID 25946117 Get It

The prevalence of burning mouth syndrome: a population-based study
Kohorst, John J. , Bruce, A.J., Torgerson, Rochelle R. , Schenck, Louis A., Davis, Mark D.P.

Mayo Clinic

British Journal of Dermatology | December 15, 2014 | Volume: 172 | Issue: 6 | Pages: 1654-1656

10.1111/bjd.13613 | PMID 25495557 Get It

Filling a critical practice gap: experience with a dermatology day treatment center at Mayo Clinic
Storan, Eoin R. , McEvoy, Marian T., Wetter, David A. , Bridges, Alina G. , Camilleri, Michael , Davis, Mark D. P. , el‐Azhary, Rokea A. , Davis, Mark D.P.

Mayo Clinic

International Journal of Dermatology | November 11, 2014 | Volume: 54 | Issue: 5 | Pages: 600-604

10.1111/ijd.12617 | PMID 25384998 Get It

AbstractBackgroundIntensive treatment options are lacking for patients with severe skin disease recalcitrant to outpatient therapy. The availability of inpatient dermatology care has almost disappeared in many parts of the United States. One possible solution for this is a day treatment center for patients with severe dermatologic disease recalcitrant to outpatient therapy.MethodsDescriptive study based on retrospective medical record review of all patients attending the day hospital for treatment in 2010. We collected data on patient demographics, distribution of admission diagnosis, treatments used, and length of stay.ResultsA total of 211 patients had 235 admissions. Mean age was 57.7 years (range 3.8–92.1 years). The most common indications for admission were dermatitis (139 admissions [59.2%]), psoriasis (58 [24.7%]), and mycosis fungoides (eight [3.4%]). The main treatment interventions were wet dressings (195 admissions [83.0%]) and Goeckerman treatment (38 [16.2%]). The median number of days of treatment was three (interquartile range, 2–5 days) for wet dressings and 22 days (interquartile range, 21–24 days) for Goeckerman therapy.ConclusionsThe dermatology day treatment center provided intensive skin‐directed therapy and filled a critical practice gap in the management of our patients with severe widespread skin diseases recalcitrant to outpatient therapy. We propose that the dermatology day treatment center is a valuable model that could be considered by both private practitioners and academic centers in the United States as an important adjunct to fill the gap in availability of intensive topical treatments for patients with severe skin disease.
Experience of a year of adult hospital dermatology consultations
Storan, Eoin R. , McEvoy, Marian T., Wetter, David A. , Camilleri, Michael , Bridges, Alina G. , Davis, Mark D. P. , El-Azhary, Rokea A, el‐Azhary, Rokea A. , Davis, Mark D.P.

Mayo Clinic

International Journal of Dermatology | November 11, 2014 | Volume: 54 | Issue: 10 | Pages: 1150-1156

10.1111/ijd.12555 | PMID 25384904 Get It

AbstractBackgroundDermatology consultations are frequently requested by inpatient hospital services. As inpatient dermatology services in the USA decline, dermatology hospital consultations are becoming increasingly important.ObjectivesWe aim to describe the spectrum of skin diseases encountered and the health care subspecialties requesting dermatology hospital consultations.MethodsWe performed a retrospective chart review of adult patient (age: ≥18 years) dermatology hospital consultations from January 1 to December 31, 2010. We examined patient demographic characteristics, consultation requesting services, and consultation diagnoses.ResultsAmong dermatology services, 614 patients had 674 separate inpatient dermatology consultations during 2010. Of these patients, 55.9% were male (mean age: 59 years). In total, 205 consultations (30.4%) were requested by the internal medicine subspecialty, 137 (20.3%) by the hematology and oncology subspecialty, and 93 (13.8%) by the surgical subspecialty. The most common conditions seen by the hospital dermatology consulting service were skin infections (n = 125, 18.5%), dermatitis (n = 120, 17.8%), drug eruptions (n = 87, 12.9%), chronic wounds and ulcers (n = 55, 8.1%), cutaneous neoplasms (n = 39, 5.8%), graft‐versus‐host disease (n = 37, 5.5%), ecchymosis, purpura simplex or petechia (n = 26, 3.8%), intertrigo (n = 21, 3.1%), and urticaria (n = 20, 3.0%).ConclusionsThe majority of consultations conducted by the dermatology hospital consulting service were for the management of common skin diseases, such as cutaneous infections, dermatitis, and drug eruptions. Most consultations were requested by the departments of internal medicine, hematology and oncology, and surgical services.
Epidemiology of Systemic Lupus Erythematosus and Cutaneous Lupus Erythematosus in a Predominantly White Population in the United States
Jarukitsopa, Sudumpai, Hoganson, Deana D., Crowson, Cynthia S. , Sokumbi, Olayemi , Davis, Mark D.P. , Michet, Clement J. , Matteson, Eric L. , Kremers, Hilal Maradit , Chowdhary, Vaidehi , Davis, Mark D., Maradit Kremers, Hilal, Chowdhary, Vaidehi R, Maradit Kremers, Hilal , Sokumbi, Olayemi

Mayo Clinic

Arthritis Care & Research | November 4, 2014 | Volume: 67 | Issue: 6 | Pages: 817-828

10.1002/acr.22502 | PMID 25369985 Get It

Objective Epidemiologic studies comparing the incidence and prevalence of systemic lupus erythematosus (SLE) and isolated cutaneous lupus erythematosus (CLE) are few. Olmsted County, Minnesota provides a unique setting for such a study owing to resources of the Rochester Epidemiology Project. We sought to describe and compare the incidence and prevalence of SLE and CLE from 1993–2005. Methods SLE cases were identified from review of medical records and fulfilled the 1982 American College of Rheumatology classification criteria. CLE cases included patients with classic discoid lupus erythematosus, subacute CLE, lupus panniculitis, and bullous lupus erythematosus. Age‐ and sex‐adjusted incidence and prevalence were standardized to the 2000 US white population. Results The age‐ and sex‐adjusted incidence of SLE (2.9 per 100,000; 95% confidence interval [95% CI] 2.0–3.7) was similar to that of CLE (4.2 per 100,000; 95% CI 3.1–5.2, P = 0.10). However, the incidence of CLE was 3 times higher than SLE in men (2.4 versus 0.8 per 100,000; P = 0.009). The age‐ and sex‐adjusted prevalence of CLE on January 1, 2006 was higher than that of SLE (70.4 versus 30.5 per 100,000; P < 0.001). The prevalences of CLE and SLE in women were similar, but the prevalence of CLE was higher in men than in women (56.9 versus 1.6 per 100,000; P < 0.001). The incidence of CLE rose steadily with age and peaked at 60–69 years. Conclusion The incidences of CLE and SLE are similar, but CLE is more common than SLE in men and in older adults. These findings may reflect differences in genetic or environmental etiology of CLE.
Patch Testing With the Standard Series When Receiving Immunosuppressive Medications
Wentworth, Ashley B., Davis, Mark D. P. , Davis, Mark D.P.

Mayo Clinic

Dermatitis® | July 4, 2014 | Volume: 25 | Issue: 4 | Pages: 195-200

10.1097/der.0000000000000048 | PMID 25000238 Get It

Background Debate surrounds the validity of patch testing for allergic contact dermatitis in patients taking immunosuppressants and the extent to which these medications suppress patch test reactions. Previous studies have demonstrated that corticosteroids can suppress immune reactions measured in patch testing. Because immunomodulators are increasingly used, their impact on patch testing also requires evaluation. Objectives This study aimed to report patch test results in patients taking specific immunosuppressants and to review relevant literature. Methods A retrospective review of patients patch tested with the standard series at Mayo Clinic in Rochester, Minnesota, between January 1, 2008, and December 31, 2011, was conducted. Conclusions Positive patch test results occur during methotrexate therapy. How reactions would differ with no immunosuppression is unclear.
Clinically Relevant Patch Test Results in Patients With Burning Mouth Syndrome
Steele, John C., Bruce, Alison J., Davis, Mark D. P. , Torgerson, Rochelle R. , Drage, Lisa A., Rogers, Roy S., Davis, Mark D.P.

Mayo Clinic

Dermatitis® | April 16, 2014 | Volume: 23 | Issue: 2 | Pages: 61-70

10.1097/der.0b013e31824a625e | PMID 22653121 Get It

Background Patients with a sore or burning mouth associated with clinically normal oral mucosa present a difficult diagnostic challenge. Objective The objective of this study was to assess the value of patch testing in patients with burning mouth syndrome. Methods We retrospectively reviewed the results of patch testing to an oral series in patients with burning mouth syndrome seen at Mayo Clinic, Rochester, Minnesota, between January 2000 and April 2006. Results Of 195 consecutive patients with a burning or sore mouth, 75 had patch testing to an oral series, and 28 of these patients (37.3%) had allergic patch test reactions. The most common allergens were nickel sulfate hexahydrate 2.5%, balsam of Peru, and gold sodium thiosulfate 0.5%. On follow-up, 15 patients reported improvement, 4 removed or avoided the offending dental metal, and 6 avoided the dietary allergen. Thirteen patients did not improve; 6 avoided identified allergens, but without improvement; 1 removed dental metals without symptom change; and 5 avoided test-positive dietary allergens but without improvement. The remaining 7 nonresponders had nonrelevant patch test results or did not avoid allergens. Conclusions Patch testing can identify patients who may be allergic to dental metals or dietary additives and who may benefit from removal or avoidance of these.
Patch Testing With Textile Allergens: The Mayo Clinic Experience
Wentworth, Ashley B., Richardson, Donna M., Davis, Mark D.P.

Mayo Clinic

Dermatitis® | April 16, 2014 | Volume: 23 | Issue: 6 | Pages: 269-274

10.1097/der.0b013e318277ca3d | PMID 23169208 Get It

Background Recognition of allergic contact dermatitis attributed to textile dyes and resins is steadily increasing. Objective This study aims to review the results of patch testing with a textile series at our institution and to compare with previously published reports. Methods We performed a retrospective review of results in patients who underwent patch testing using a series of textile dyes and resins from January 1, 2000, through September 30, 2011. Results A total of 671 patients (mean age, 56.5 years; female, 65.9%) were patch tested with the textile series (42 dyes and resins). These patients were also generally tested with the standard patch test series (n = 620). Of the patients, 219 (32.6%) demonstrated allergic reaction to 1 or more textile dyes and resins, and 71 (10.6%) manifested irritant reactions. The most frequent allergens were disperse blue 106 1% (8.3%), disperse blue 124 1% (8.0%), and melamine formaldehyde 7% (8.0%). Of patients tested with the standard series, 36 (5.8%) showed a positive reaction to the traditional textile screening allergen p -phenylenediamine 1%. Conclusions Supplementing the standard series with the textile series increased detection of textile allergies. In patients suspected of textile allergy, addition of the textile series is necessary for appropriate diagnosis.
Allergy to Cosmetics
Alani, Jennifer I., Davis, Mark D.P. , Yiannias, James A.

Mayo Clinic

Dermatitis® | April 16, 2014 | Volume: 24 | Issue: 6 | Pages: 283-290

10.1097/der.0b013e3182a5d8bc | PMID 24201464 Get It

The term cosmetic has a broad definition and includes personal care products, hair care products, nail care products, and sunscreens. Modern cosmetics are safe for most users, and adverse reactions are very rare because the manufacturers invest heavily in safety, quality control, and product testing before releasing the product to the market. Despite these efforts, adverse reactions occur. Skin care products are major contributors to cosmetic allergic contact dermatitis (ACD), followed by hair care and nail care products. The most common allergens are fragrances and preservatives. The diagnosis of cosmetic allergy is established by reviewing the patient’s clinical history and physical examination findings and confirmed with skin patch testing. Patch testing is the standard method for detecting allergens responsible for eliciting ACD. The purpose of this article was to review the prevalence, legislative laws, and role of patch testing in ACD.
Plain radiography is effective for the detection of calcinosis cutis occurring in association with autoimmune connective tissue disease
Shahi, Varun, Wetter, David A. , Howe, B. Matthew, Ringler, Michael D. , Davis, Mark D. P. , Davis, Mark D.P.

Mayo Clinic

British Journal of Dermatology | December 16, 2013 | Volume: 170 | Issue: 5 | Pages: 1073-1079

10.1111/bjd.12785 | PMID 24329416 Get It